Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
Molecules · 2023
DOI: 10.3390/molecules28031283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Zi-Hua Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kaifeng Hospital of Traditional Chinese Medicine, No. 54 East Caizhengting St., Kaifeng 475000, China. Hauptthemen laut MEDLINE: Central Nervous System Diseases, Nanoparticles. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 312 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Foundation of Science and Technology Department of Henan Province, China, Training Program for Young Backbone Teachers of Institutions of Higher Learning in Henan Province.
Abstract (Originalsprache)
Central nervous system disorders, especially neurodegenerative diseases, are a public health priority and demand a strong scientific response. Various therapy procedures have been used in the past, but their therapeutic value has been insufficient. The blood–brain barrier (BBB) and the blood–cerebrospinal fluid barrier is two of the barriers that protect the central nervous system (CNS), but are the main barriers to medicine delivery into the CNS for treating CNS disorders, such as brain tumors, Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease. Nanotechnology-based medicinal approaches deliver valuable cargos targeting molecular and cellular processes with greater safety, efficacy, and specificity than traditional approaches. CNS diseases include a wide range of brain ailments connected to short- and long-term disability. They affect millions of people worldwide and are anticipated to become more common in the coming years. Nanotechnology-based brain therapy could solve the BBB problem. This review analyzes nanomedicine’s role in medication delivery; immunotherapy, chemotherapy, and gene therapy are combined with nanomedicines to treat CNS disorders. We also evaluated nanotechnology-based approaches for CNS disease amelioration, with the intention of stimulating the immune system by delivering medications across the BBB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Kaifeng Hospital of Traditional Chinese Medicine, No. 54 East Caizhengting St., Kaifeng 475000, China.
- Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
- Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
- Henan-Macquarie University Joint Centre for Biomedical Innovation, School of Life Sciences, Henan University, Kaifeng 475004, China.
- Department of Epidemic Disease Research, Institute for Research & Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
- National Centre for Biotechnology, King Abdulaziz City for Science and Technology (KACST), P.O. Box 6086, Riyadh 11442, Saudi Arabia.
ORCID-Profile: Mohd Ahmar Rauf, Mohammad Azam Ansari, Mohammad N Alomary, Sufyan Razak, Dong-Dong Wu
Förderung
- National Natural Science Foundation of China
- Foundation of Science and Technology Department of Henan Province, China
- Training Program for Young Backbone Teachers of Institutions of Higher Learning in Henan Province
Zitieren
APA
Guo, Z. H., Khattak, S., Rauf, M. A., Ansari, M. A., Alomary, M. N., Razak, S., Yang, C. Y., Wu, D. D., & Ji, X. Y. (2023). Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders. Molecules. https://doi.org/10.3390/molecules28031283
Vancouver
Guo ZH, Khattak S, Rauf MA, Ansari MA, Alomary MN, Razak S, et al. Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders. Molecules. 2023. doi:10.3390/molecules28031283
BibTeX
@article{Guo2023,
author = {Guo, Zi-Hua and Khattak, Saadullah and Rauf, Mohd Ahmar and Ansari, Mohammad Azam and Alomary, Mohammad N and Razak, Sufyan and Yang, Chang-Yong and Wu, Dong-Dong and Ji, Xin-Ying},
title = {Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28031283}
}
EUVIMED